Peritonitis complicating continuous ambulatory peritoneal dialysis in Nottingham 1983–1988

References

1. Brunner F. P., Broyer M., Brynger H. Combined report on regular dialysis and transplantation in Europe. XV.1984 Proc Eur Dial Transpl Ass 1985; 22:3–53
   [Google Scholar]
2. Morgan A. G., Burden R. P. Effect of continuous ambulatory peritoneal dialysis on a British renal unit. Br Med J 1986; 293:935–937
   [Google Scholar]
3. Working P. a.rty of the British Society for Antimicrobial Chemotherapy. Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1987; 1:845–849
   [Google Scholar]
4. Greaves P. W. New methods for the isolation of Neisseria gonorrhoeae. J Clin Pathol 1980; 33:581–584
   [Google Scholar]
5. Cowan S. T. Cowan and Steel’s Manual for the identification of medical bacteria. London: Cambridge University Press; 1974
   [Google Scholar]
6. Barry A. L. The antimicrobic susceptibility test: principles and practices. Philadelphia: Lea and Febiger; 1976
   [Google Scholar]
7. Stokes E. J., Waterworth P. M. Antibiotic sensitivity tests by diffusion methods. Association of Clinical Pathologists Broadsheet No. 55 (revised) 1972
   [Google Scholar]
8. Slingeneyer A., Mion C., Beraud J. J., Oules R., Branger B., Balmers M. Peritonitis, a frequently lethal complication of intermittent and continuous ambulatory peritoneal dialysis. Proc Eur Dial Transpl Ass 1981; 18:212–221
   [Google Scholar]
9. Gokal R., Ramos J. M., Francis D. M. A. Peritonitis in continuous ambulatory peritoneal dialysis Laboratory and clinical studies. Lancet 1982; 2:1388–1391
   [Google Scholar]
10. Prowant B., Nolph K., Ryan L., Twardowski Z., Khanna R. Peritonitis in continuous ambulatory peritoneal dialysis: analysis of an 8-year experience. Nephron 1986; 43:105–109
    [Google Scholar]
11. Tranaeus A., Heimburger O., Lindholm B. Peritonitis during continuous ambulatory peritoneal dialysis (CAPD): risk factors, clinical severity, and pathogenetic aspects. Periton Dial Bull 1988; 8:253–263
    [Google Scholar]
12. Churchill D. N., Lavoie S., Deveber G. A. Peritonitis in continuous ambulatory peritoneal dialysis—a multi-centre randomized clinical trial comparing the Y-connector disinfectant system to standard systems. Periton Dial Int 1989; 9:159–163
    [Google Scholar]
13. Verbrugh H. A., Keane W. F., Hoidal J. R., Freiberg M. R., Elliott G. R., Peterson P. K. Peritoneal macrophages and opsonins: antibacterial defence in patients undergoing chronic peritoneal dialysis. Infect Dis 1983; 147:1018–1029
    [Google Scholar]
14. Holmes C. J., Evans R. Biofilm and foreign body infection—the significance to CAPD-associated peritonitis. Periton Dial Bull 1986; 6:168–177
    [Google Scholar]
15. Peters G. New considerations in the pathogenesis of coagulase-negative staphylococcal foreign body infections. J Anti-microb Chemother 1988; 21: Suppl C 139–148
    [Google Scholar]
16. Keane W. F., Everett E. D., Fine R. N., Golper T. A., Peterson P. K., Vas S. I. CAPD related peritonitis—management and antibiotic therapy recommendations. Periton Dial Bull 1987; 7:55–68
    [Google Scholar]
17. Craddock C. F., Edwards R., Finch R. G. Pseudomonas peritonitis in continuous ambulatory peritoneal dialysis: laboratory predictors of treatment failure. J Hosp Infect 1987; 10:179–186
    [Google Scholar]
18. Wilcox M. H., Edwards R., Finch R. G. Laboratory studies on coagulase-negative staphylococci from CAPD-peritonitis. J Antimicrob Chemother 1985; 15:297–303
    [Google Scholar]
19. Gokal R., Mistry C. D., Monos J. Peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Netilmicin—a perspective of 5 years of clinical experience in UK. Franklin Scientific Publications 198724–27
    [Google Scholar]